Resources

Products

Applications

About MGI

Resources

Products

Applications

About MGI

MGI's Impact at the AfricaBP Workshop in Morocco

10/9/23

10/13/23

Offline

Morocco

Share

MGI left a lasting impact at the AfricaBP Workshop in Morocco, fostering collaboration in genomics and contributing to biodiversity research through its innovative DNBSEQ Technology.
MGI left a lasting impact at the AfricaBP Workshop in Morocco, fostering collaboration in genomics and contributing to biodiversity research through its innovative DNBSEQ Technology.
MGI left a lasting impact at the AfricaBP Workshop in Morocco, fostering collaboration in genomics and contributing to biodiversity research through its innovative DNBSEQ Technology.

From October 9th to 15th, 2023, MGI exhibited at the African Biogenome Project (AfricaBP) Open Institute for Genomic and Bioinformatics North Africa Workshop held in Morocco.

This five-day event facilitated connections among scientists and institutes contributing to the AfricaBP initiative, fostering collaboration in exploring and sequencing genomes of African species.

Dr. AYOUB SABRI, MGI’s North Africa Sales Channel Manager, delivered a presentation on MGI’s DNBSEQ Technology, providing a valuable sequencing choice for the North African market.

The exhibition underscored MGI's commitment to advancing genomics and supporting AfricaBP's biodiversity research. As we reflect, we look forward to potential future collaborations in genomics.

From October 9th to 15th, 2023, MGI exhibited at the African Biogenome Project (AfricaBP) Open Institute for Genomic and Bioinformatics North Africa Workshop held in Morocco.

This five-day event facilitated connections among scientists and institutes contributing to the AfricaBP initiative, fostering collaboration in exploring and sequencing genomes of African species.

Dr. AYOUB SABRI, MGI’s North Africa Sales Channel Manager, delivered a presentation on MGI’s DNBSEQ Technology, providing a valuable sequencing choice for the North African market.

The exhibition underscored MGI's commitment to advancing genomics and supporting AfricaBP's biodiversity research. As we reflect, we look forward to potential future collaborations in genomics.

From October 9th to 15th, 2023, MGI exhibited at the African Biogenome Project (AfricaBP) Open Institute for Genomic and Bioinformatics North Africa Workshop held in Morocco.

This five-day event facilitated connections among scientists and institutes contributing to the AfricaBP initiative, fostering collaboration in exploring and sequencing genomes of African species.

Dr. AYOUB SABRI, MGI’s North Africa Sales Channel Manager, delivered a presentation on MGI’s DNBSEQ Technology, providing a valuable sequencing choice for the North African market.

The exhibition underscored MGI's commitment to advancing genomics and supporting AfricaBP's biodiversity research. As we reflect, we look forward to potential future collaborations in genomics.

From October 9th to 15th, 2023, MGI exhibited at the African Biogenome Project (AfricaBP) Open Institute for Genomic and Bioinformatics North Africa Workshop held in Morocco.

This five-day event facilitated connections among scientists and institutes contributing to the AfricaBP initiative, fostering collaboration in exploring and sequencing genomes of African species.

Dr. AYOUB SABRI, MGI’s North Africa Sales Channel Manager, delivered a presentation on MGI’s DNBSEQ Technology, providing a valuable sequencing choice for the North African market.

The exhibition underscored MGI's commitment to advancing genomics and supporting AfricaBP's biodiversity research. As we reflect, we look forward to potential future collaborations in genomics.

About MGI

MGI Tech Co., Ltd. (MGI) is at the forefront of global innovation, actively contributing to life science through intelligent innovation. With a presence in over 100 countries and a customer base of 2600+, MGI's cutting-edge technology has been instrumental in the development of 736+ user patents, facilitating the creation of over 150 petabytes of data. The company's extensive portfolio includes sequencing instruments, automation instruments, reagents, and related products that cater to various sectors such as life science research, agriculture, precision medicine, and healthcare.

MGI is dedicated to advancing life science tools for the healthcare of the future. As of December 2021, the company's global presence has expanded to more than 100 countries and regions, serving over 1,300 international clients. With a workforce of over 2,900 professionals worldwide, including 5 centers for research and development and production facilities in Europe, MGI is committed to fostering innovation. Approximately 35% of MGI's employees are engaged in R&D, underscoring the company's focus on pioneering advancements in the field.

The impact of MGI's work is further evidenced by the publication of over 6,800 papers in prestigious scientific journals, showcasing the significant contribution of MGI's technology to the scientific community and beyond.

For more information about MGI and its contributions to life science and healthcare, please visit the MGI website or connect with us on Twitter, LinkedIn, or YouTube.

About MGI

MGI Tech Co., Ltd. (MGI) is at the forefront of global innovation, actively contributing to life science through intelligent innovation. With a presence in over 100 countries and a customer base of 2600+, MGI's cutting-edge technology has been instrumental in the development of 736+ user patents, facilitating the creation of over 150 petabytes of data. The company's extensive portfolio includes sequencing instruments, automation instruments, reagents, and related products that cater to various sectors such as life science research, agriculture, precision medicine, and healthcare.

MGI is dedicated to advancing life science tools for the healthcare of the future. As of December 2021, the company's global presence has expanded to more than 100 countries and regions, serving over 1,300 international clients. With a workforce of over 2,900 professionals worldwide, including 5 centers for research and development and production facilities in Europe, MGI is committed to fostering innovation. Approximately 35% of MGI's employees are engaged in R&D, underscoring the company's focus on pioneering advancements in the field.

The impact of MGI's work is further evidenced by the publication of over 6,800 papers in prestigious scientific journals, showcasing the significant contribution of MGI's technology to the scientific community and beyond.

For more information about MGI and its contributions to life science and healthcare, please visit the MGI website or connect with us on Twitter, LinkedIn, or YouTube.

About MGI

MGI Tech Co., Ltd. (MGI) is at the forefront of global innovation, actively contributing to life science through intelligent innovation. With a presence in over 100 countries and a customer base of 2600+, MGI's cutting-edge technology has been instrumental in the development of 736+ user patents, facilitating the creation of over 150 petabytes of data. The company's extensive portfolio includes sequencing instruments, automation instruments, reagents, and related products that cater to various sectors such as life science research, agriculture, precision medicine, and healthcare.

MGI is dedicated to advancing life science tools for the healthcare of the future. As of December 2021, the company's global presence has expanded to more than 100 countries and regions, serving over 1,300 international clients. With a workforce of over 2,900 professionals worldwide, including 5 centers for research and development and production facilities in Europe, MGI is committed to fostering innovation. Approximately 35% of MGI's employees are engaged in R&D, underscoring the company's focus on pioneering advancements in the field.

The impact of MGI's work is further evidenced by the publication of over 6,800 papers in prestigious scientific journals, showcasing the significant contribution of MGI's technology to the scientific community and beyond.

For more information about MGI and its contributions to life science and healthcare, please visit the MGI website or connect with us on Twitter, LinkedIn, or YouTube.

About MGI

MGI Tech Co., Ltd. (MGI) is at the forefront of global innovation, actively contributing to life science through intelligent innovation. With a presence in over 100 countries and a customer base of 2600+, MGI's cutting-edge technology has been instrumental in the development of 736+ user patents, facilitating the creation of over 150 petabytes of data. The company's extensive portfolio includes sequencing instruments, automation instruments, reagents, and related products that cater to various sectors such as life science research, agriculture, precision medicine, and healthcare.

MGI is dedicated to advancing life science tools for the healthcare of the future. As of December 2021, the company's global presence has expanded to more than 100 countries and regions, serving over 1,300 international clients. With a workforce of over 2,900 professionals worldwide, including 5 centers for research and development and production facilities in Europe, MGI is committed to fostering innovation. Approximately 35% of MGI's employees are engaged in R&D, underscoring the company's focus on pioneering advancements in the field.

The impact of MGI's work is further evidenced by the publication of over 6,800 papers in prestigious scientific journals, showcasing the significant contribution of MGI's technology to the scientific community and beyond.

For more information about MGI and its contributions to life science and healthcare, please visit the MGI website or connect with us on Twitter, LinkedIn, or YouTube.

COLLABORATION

AFRICABP

MOROCCO

BIODIVERSITY

MABIOTECH

Share this article :

Share

Sep 10, 2024

MGI Tech Unveils its SEQ ALL landscape at the Future of Omics Conference

Discover insights from the "Future of Omics" event, where leading experts discussed innovations in genomics, proteomics, and metabolomics. Explore key takeaways on advancing research and technology, shaping the future of personalized medicine and healthcare. Join us in celebrating the progress in omics!

Jun 1, 2024

MGI Tech Shares New Data on Core DNEBSEQ Technology and Showcases Latest Sequencing Innovations at ESHG 2024

MGI showcased its latest innovations at the ESHG 2024, highlighting the upgraded StandardMPS 2.0 sequencing chemistry and unveiling the new DNBelab C-TaiM 4 Single-Cell Droplet Generator. European researchers presented advancements in diagnostics, population health, and more.

Apr 27, 2024

MGI Tech Showcases Life Science Excellence at ESCMID Global 2024 with Latest DNBSEQ-E25 Sequencer and New Partnership with ABL Diagnostics

MGI introduced its portable DNBSEQ-E25 sequencer at ESCMID Global 2024, designed for mobile and efficient genomic sequencing with applications in infectious diseases. Additionally, MGI announced a partnership with ABL Diagnostics to integrate DeepChek® assays into its platforms, broadening NGS solutions for microbiology labs.

Join our newsletter to stay up to date on features and releases.

I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.

*For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.

Join our newsletter to stay up to date on features and releases.

I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.

*For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.

Join our newsletter to stay up to date on features and releases.

I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.

*For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.

Join our newsletter to stay up to date on features and releases.

I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.

*For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.